NCT05684016View on ClinicalTrials.gov

Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
OTHER

NeuroQuant

Reliably defines the volume of those parts of the brain that are important for memory and thinking.

OTHER

Automated Neuropsychological Assessment Matrices

This is like an IQ test.

OTHER

EDSS

Extended Disability Status Score

OTHER

Physical Examination

Physical Examination

Trial Locations (1)

20037

The George Washignton University, Washington D.C.

All Listed Sponsors
lead

George Washington University

OTHER

NCT05684016 - Assessment of Deep Gray Matter Anatomic Changes in RRMS Patients Treated With Gilenya® With and Without Cognitive Impairment Over a 2 Year Period Using NeuroQuant, NeuroQuarc and ANAM | Biotech Hunter | Biotech Hunter